Precision NanoSystems has received a contribution of up to $25.1 million from the Government of Canada's Strategic Innovation Fund to help build Canada’s first centre of manufacturing excellence of nanomedicine-based ribonucleic acid (RNA) vaccines, gene therapies and cell therapies.
Read the Precision Nanosystems News Release